Among the 81 ccRCC patients, those with lower MRPL12 K163 acetylation levels demonstrated significantly poorer overall survival compared to patients with higher acetylation levels (Fig. 2D). Here, MRPL12 is linked to nonpapillary renal cell carcinoma.